// App-Quantinova.ai

S2120 2015 AHA : Persistence with Antiarrhythmic Agents in Atrial Fibrillation: Insights From the Veterans Health Administration

Researchers

Presenter

  • Mintu Turakhia

Principal Investigators

  • Vidal Essebag

  • Karin H Humphries

  • P. Michael Ho

  • Louise Pilote

  • Thomas Glorioso

  • Jack V Tu

  • Meytal Tsadok

  • Mark J Eisenberg

  • Clare Atzema

  • Lingyun Lu

  • Elham Rahme

Medical Centers

  • U Colorado, Denver, CO

  • The University of British Columbia, Vancouver, BC, Canada

  • Univ of Toronto, Schulich Heart Ctr and Sunnybrook Health Sciences Ctr, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • McGill Univ Health Ctr, Montreal, Canada

  • McGill Univ Health Ctr, Montreal, Canada

  • Western Univ of Health Sciences and Inst for Clinical Evaluative Sciences, Pomona, CA

  • Western University of Health Sciences, Los Angeles, CA

  • Univ of Colorado, Aurora, CO

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Amiodarone Hydrochloride

  • Dofetilide

  • Sotalol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved